Caroline Farrington

847 total citations
10 papers, 447 citations indexed

About

Caroline Farrington is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Caroline Farrington has authored 10 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 2 papers in Genetics and 2 papers in Immunology. Recurrent topics in Caroline Farrington's work include Cell death mechanisms and regulation (3 papers), Ubiquitin and proteasome pathways (3 papers) and Protein Degradation and Inhibitors (3 papers). Caroline Farrington is often cited by papers focused on Cell death mechanisms and regulation (3 papers), Ubiquitin and proteasome pathways (3 papers) and Protein Degradation and Inhibitors (3 papers). Caroline Farrington collaborates with scholars based in United States, Spain and Poland. Caroline Farrington's co-authors include Goutham Narla, Matthew D. Galsky, Jaya Sangodkar, Kimberly McClinch, David B. Kastrinsky, Rui Yuan, Sudeh Izadmehr, Sahar Mazhar, Rosalie C. Sears and David L. Brautigan and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Caroline Farrington

10 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caroline Farrington United States 8 353 111 77 50 46 10 447
Jung Yoo South Korea 14 400 1.1× 122 1.1× 107 1.4× 51 1.0× 38 0.8× 19 529
Amriti R. Lulla United States 11 277 0.8× 135 1.2× 97 1.3× 60 1.2× 42 0.9× 24 434
Xingling Zheng China 9 322 0.9× 89 0.8× 95 1.2× 28 0.6× 38 0.8× 12 431
Kalle Ojala Finland 6 236 0.7× 85 0.8× 76 1.0× 48 1.0× 38 0.8× 12 334
Lucia García-Gutiérrez Spain 9 305 0.9× 132 1.2× 62 0.8× 68 1.4× 27 0.6× 15 417
Leandro H. Gallo United States 5 256 0.7× 88 0.8× 65 0.8× 26 0.5× 38 0.8× 7 327
Hexiu Su China 8 281 0.8× 107 1.0× 124 1.6× 64 1.3× 25 0.5× 11 383
Ami Albihn Sweden 8 323 0.9× 127 1.1× 83 1.1× 38 0.8× 22 0.5× 8 426
Zhen Ning Wee Singapore 4 267 0.8× 111 1.0× 113 1.5× 71 1.4× 46 1.0× 4 385
Silvia Licciulli Italy 8 366 1.0× 127 1.1× 83 1.1× 59 1.2× 38 0.8× 8 470

Countries citing papers authored by Caroline Farrington

Since Specialization
Citations

This map shows the geographic impact of Caroline Farrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Farrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Farrington more than expected).

Fields of papers citing papers by Caroline Farrington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Farrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Farrington. The network helps show where Caroline Farrington may publish in the future.

Co-authorship network of co-authors of Caroline Farrington

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Farrington. A scholar is included among the top collaborators of Caroline Farrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Farrington. Caroline Farrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Jayappa, Kallesh D., Vicki L. Gordon, Christopher G. Morris, et al.. (2023). PP2A modulation overcomes multidrug resistance in chronic lymphocytic leukemia via mPTP-dependent apoptosis. Journal of Clinical Investigation. 133(13). 10 indexed citations
2.
Jayappa, Kallesh D., Caroline Farrington, Anuradha Illendula, et al.. (2022). Nanoliposomal C6-Ceramide Exhibits Synergistic Anti-Cancer Activity with a Small Molecule Agonist of PP2A in Chronic Lymphocytic Leukemia. Blood. 140(Supplement 1). 7816–7817. 1 indexed citations
3.
Farrington, Caroline, Elena Arriazu, Nerea Marcotegui, et al.. (2022). Activation of the PP2A-B56α heterocomplex synergizes with venetoclax therapies in AML through BCL2 and MCL1 modulation. Blood. 141(9). 1047–1059. 15 indexed citations
4.
Brautigan, David L., Caroline Farrington, & Goutham Narla. (2021). Targeting protein phosphatase PP2A for cancer therapy: development of allosteric pharmaceutical agents. Clinical Science. 135(13). 1545–1556. 17 indexed citations
5.
Farrington, Caroline, Rui Yuan, Sahar Mazhar, et al.. (2020). Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers. Journal of Biological Chemistry. 295(3). 757–770. 36 indexed citations
6.
Risom, Tyler, Xiaoyan Wang, Juan Liang, et al.. (2019). Deregulating MYC in a model of HER2+ breast cancer mimics human intertumoral heterogeneity. Journal of Clinical Investigation. 130(1). 231–246. 31 indexed citations
7.
Farrington, Caroline, Rui Yuan, Sahar Mazhar, et al.. (2019). Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers. Journal of Biological Chemistry. 295(3). 757–770. 32 indexed citations
8.
Sangodkar, Jaya, Caroline Farrington, Kimberly McClinch, et al.. (2015). All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase. FEBS Journal. 283(6). 1004–1024. 234 indexed citations
9.
Sangodkar, Jaya, Neil S. Dhawan, Rui Yuan, et al.. (2012). Targeting the FOXO1/KLF6 axis regulates EGFR signaling and treatment response. Journal of Clinical Investigation. 122(7). 2637–2651. 70 indexed citations
10.
Sangodkar, Jaya, Neil S. Dhawan, Caroline Farrington, et al.. (2012). Abstract 1885: Targeting the FOXO1/KLF6 transcriptional network to modulate response to anti-EGFR based therapy. Cancer Research. 72(8_Supplement). 1885–1885. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jung Yoo Breakdown of academic impact, for papers by Amriti R. Lulla Breakdown of academic impact, for papers by Xingling Zheng Breakdown of academic impact, for papers by Kalle Ojala Breakdown of academic impact, for papers by Lucia García-Gutiérrez Breakdown of academic impact, for papers by Leandro H. Gallo Breakdown of academic impact, for papers by Hexiu Su Breakdown of academic impact, for papers by Ami Albihn Breakdown of academic impact, for papers by Zhen Ning Wee Breakdown of academic impact, for papers by Silvia Licciulli
Rankless by CCL
2026